Dec 22, 2024, 13:20 | Science

Bladder sparing Therapy for Bacillus unresponsive invasive Bladder Cancer - European Urology

European Urology shared a recent article by Roger Li on X: "Review: Bladder-sparing Therapy for…

Dec 20, 2024, 15:46 | Career

Thomas Powles was awarded the Gordon Hamilton Fairley Medal

Barts Cancer Institute (Queen Mary University of London) shared a post on LinkedIn: “The BCI…

Dec 20, 2024, 12:16 | Science

Laura Bukavina: Microbiome analysis of Fresh Frozen vs FFPE tissue in bladder cancer by Dominik Enderlin et al.

A recent paper by Dominik Enderlin, Urology Resident at the University Hospital of Zurich, published…

Dec 19, 2024, 16:41 | Blog

Survival after trimodal therapy in organ-confined bladder cancer

Enrique Grande, Associate Professor at Francisco de Vitoria University, shared an article by Mattia Longoni…

Dec 19, 2024, 14:08 | Blog

Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation

Enrique Grande shared on X: "Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer…

Dec 18, 2024, 06:52 | Blog

Gregory Maes: Representing Nonacus during General Assembly of the ELBS

Gregory Maes, Global Pharma and Strategic Alliances Manager at Nonacus, shared a post on LinkedIn:…

Dec 17, 2024, 23:36 | Blog

Durvalumab and chemotherapy improves survival in MIBC - Uro Today

UroToday.com shared a post on X: "NIAGARA trial shows durvalumab + chemotherapy improves survival in…

Dec 16, 2024, 17:22 | Blog

Shilpa Gupta: Global impact of IBCG Bladder Cancer discussed at GUInc Retreat

Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, posted the following on X: “Such an…

Dec 16, 2024, 08:25 | Science

Laura Bukavina: Higher complications in ileal conduit patients versus neobladder patients

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, posted the…

Dec 14, 2024, 07:33 | Blog

Advancing Treatment Strategies for Muscle-Invasive Bladder Cancer - Mediamedic

Mediamedic shared a post on LinkedIn: "Revolutionizing Muscle-Invasive Bladder Cancer Treatment. At ESMO Asia 2024,…

Dec 8, 2024, 06:30 | Insight

Tom Powles: Cisplatin or Carboplatin-Based Chemotherapy with Pembrolizumab in Advanced Urothelial Cancer

Tom Powles, Director of Barts Cancer Centre, shared a recent article on X: "While EVP…

Dec 8, 2024, 06:29 | Blog

Guru P. Sonpavde: Year in Review 2024 - Bladder Cancer

Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared a post on…

Dec 7, 2024, 19:49 | Blog

Tom Powles: Impressive bladder cancer sessions for Asian subsets at ESMO Asia 2024

Tom Powles, The Director of Barts Cancer Centre, a CRUK Major Cancer Centre, posted on…

Dec 7, 2024, 01:55 | Insight

Andrea Necchi: Bladder Preservation vs Radical Cystectomy in Locally Advanced Muscle-Invasive Bladder Cancer

Andrea Necchi, Associate Editor of the Journal of Clinical Oncology, shared a post on X:…

Dec 7, 2024, 01:50 | Blog

Enrique Grande: Honored to participate in ESMO Asia 2024 in Singapore

Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on LinkedIn: "Honored to participate…

Dec 6, 2024, 16:44 | Insight

Emanuele Crupi: Nectin-4 Positivity in GU Malignancies

Emanuele Crupi, Fellow in Medical Oncology at San Raffaele University-Hospital, shared a post on LinkedIn…

Dec 5, 2024, 22:48 | Blog

Enrique Grande: FGFR inhibitors shaping the future of precision medicine

Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, posted the following on…

Dec 5, 2024, 01:56 | Blog

Bladder Cancer Advocacy Network’s $300K Research Innovation Award

Bladder Cancer Advocacy Network shared a post on X: "Calling innovators. Have a bold idea…

Dec 3, 2024, 19:10 | Blog

Does the target of enfortumab vedotin play a significant role in the treatment of bladder cancer?

International Urology Cancer Summit shared on X: "Does the target of enfortumab vedotin play a significant…

Dec 3, 2024, 09:45 | Blog

Live symposia by NCCN: Expert insights on Bladder Cancer and the latest updates on CLL

National Comprehensive Cancer Network shared a post on LinkedIn: "Join us for live symposia this…

Dec 2, 2024, 17:57 | Blog

Petros Grivas: Ananya Choudhury on histology subtypes of Bladder Cancer

Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington, shared…

Nov 30, 2024, 23:26 | Insight

Cristiane D Bergerot: Comprehensive care is key in Bladder Cancer

Cristiane D Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared…

Nov 30, 2024, 18:59 | Insight

Paulo G Bergerot: How exercise nutrition and psychosocial support improve outcomes in Cancer care

Cristiane D. Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared…

Nov 29, 2024, 15:54 | Insight

Highlights from BLADDR 2024 by María Natalia Gandur Quiroga

BLADDR 2o24, Second session of the ongoing RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU Oncology,…

Nov 29, 2024, 10:54 | Blog

Mieke Van Hemelrijck: "Supporting patients and improving patient communication"

Mieke Van Hemelrijck, Professor of Cancer Epidemiology at King’s College London, posted on LinkedIn: "Another…

Nov 27, 2024, 11:39 | Immune Oncology

Immunotherapy for Bladder Cancer: Types, Success Rate, Side Effects & More

Immunotherapy has become a transformative approach in treating bladder cancer, utilizing the immune system to…

Nov 26, 2024, 16:42 | Blog

Tian Zhang: STAREV is open and enrolling UTSW Simmons Cancer Center

Tian Zhang, Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center,…

Nov 25, 2024, 17:42 | Blog

Robot-assisted radical cystectomy vs open radical cystectomy for bladder cancer

Enrique Grande, Associate Professor at Francisco de Vitoria University, posted on X about recent paper…

Nov 24, 2024, 19:20 | Insight

Laura Bukavina: The Urinary and Gut Microbiome role in Bladder Cancer

Laura Bukavina, Urologic Oncologist at Cleveland Clinic Urology and Associate Editor of European Urology, shared…

Nov 24, 2024, 18:04 | Blog

Meet the experts of USANZ 77th Annual Scientific Meeting

USANZ shared a post on X: "Meet the experts- Introducing Dr. Laura Bukavina from Case…

Nov 24, 2024, 13:21 | Blog

Bladder Cancer Updates from the second half of 2024

Danny Burke, CEO at Ecancer, shared a post on LinkedIn: "Join our live broadcast covering…

Nov 15, 2024, 15:10 | Insight

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…

Nov 15, 2024, 12:02 | Insight

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Bladder Cancer

Yakup Ergün, Medical Oncologist at Bower Hospital, shared a post on X: "Perioperative Durvalumab with…

Nov 13, 2024, 10:37 | Insight

UCLA: Combination approach shows promise for treating rare, aggressive cancers

UCLA research finds that combining immunotherapy with chemotherapy is safe and effective for people with…

Nov 12, 2024, 00:31 | Blog

Welcoming Carlos Del Fresno and Marta Dueñas Porta to the next edition of Richi Entrepreneurs

Richi Entrepreneurs shared a post on LinkedIn: " We are excited to welcome Carlos Del Fresno…

Nov 10, 2024, 18:05 | Insight

Update on results of the SWOG Cancer Research Network S1011 trial from the NCI Cancer Currents blog

SWOG Cancer Research Network, shared a post on X: “From NCI Cancer Currents blog, an…

Nov 9, 2024, 19:37 | Blog

Omar Alhalabi: Advancing Knowledge on Aggressive Bladder Cancer Subtypes

Omar Alhalabi, Genitourinary Medical Oncologist at MD Anderson Cancer Center, shared an X: “Hot off…

Nov 9, 2024, 16:57 | Insight

The critical role of (p)rehabilitation interventions in the broad management of Bladder Cancer

ACS Journal Cancer shared on X: "A newly published scoping review led by Logan Briggs highlights…

Nov 7, 2024, 00:11 | Blog

Chandler Park's Insights on the SunRISe Program and the Potential of TAR-200 for High-Risk Bladder Cancer

Chandler Park, Kentucky Physician Representative at ASCO State Executive Council, shared a post by Topline Bio on…

Nov 5, 2024, 17:59 | Insight

Guru Sonpavde: Meta-analysis of adjuvant PD1/L1 inhibitor immunotherapy in MIBC

Guru Sonpavde, Oncology and Phase I Clinical Trials Director at AdventHealth Central Florida, shared a…

Nov 5, 2024, 01:12 | Blog

Shilpa Gupta: NIAGARA trial insights on bladder cancer treatment

Shilpa Gupta shared a post by UroToday on X, adding the following: “Had a great…

Nov 1, 2024, 08:06 | Insight

Vérane Achard: Our editorial on the long-term results of the RTOG 0712

Vérane Achard, Radiation Oncologist and Chief Clinical Director at Fribourg Cantonal Hospital, shared a post…

Oct 29, 2024, 10:29 | Blog

Guru Sonpavde: Pleased to discuss bladder cancer highlights at ESMO East conference

Guru Sonpavde posted on LinkedIn: "ESMO24 bladder cancer highlights: Pleased to discuss from AdventHealth Central…

Oct 29, 2024, 09:31 | Blog

Tumor Board Tuesday on HER2 options for metastatic bladder cancer

Tumor Board Tuesday shared a post on X: "It is amazing how many HER2 options there…

Oct 28, 2024, 09:49 | Insight

Ashish M. Kamat: What is the impact of sex on outcomes in NMIBC?

Ashish M. Kamat, President, IBCG, shared a post on X: "What is the impact of…

Oct 26, 2024, 12:45 | Insight

Shilpa Gupta’s Highlights from SIU 2024

The 44th Annual Congress of the Société Internationale d'Urologie (SIU) took place in the vibrant city of…

Oct 25, 2024, 18:53 | Blog

Matthew Kurian: St. Elizabeth leading the charge for educating healthcare providers in NKY area

Matthew Kurian shared a post on LinkedIn: ''Great to see St. Elizabeth leading the charge…

Oct 23, 2024, 03:13 | Blog

Mieke Van Hemelrijck: Early bird registration for the 7th Bladder Cancer Translational Research Meeting is open!

Mieke Van Hemelrijck shared on Linkedin: ''Join TOUR: Transforming cancer OUtcomes through Research for the…

Oct 21, 2024, 19:19 | Blog

Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials

Guru Sonpavde shared a post on LinkedIn: ''ESMO24 bladder cancer potentially practice-changing highlights from 2…

Oct 19, 2024, 18:33 | Blog

Common early signs to look out for when it comes to bladder cancer - World Bladder Cancer Patient Coalition

World Bladder Cancer Patient Coalition shared a post on X: "Know the most common early…

Oct 19, 2024, 16:16 | Blog

Early results from a Phase 1 trial of Aura Biosciences drug bel-sar (AU-011)

Aura Biosciences announced early results from a Phase 1 trial of its drug bel-sar (AU-011)…

Oct 18, 2024, 19:24 | Blog

Bladder preservation in muscle-invasive bladder cancer - 57th Urology Course

57th Urology Course posted on LinkedIn: "Debate: Bladder preservation in muscle-invasive bladder cancer. Bladder preservation…

Oct 18, 2024, 14:11 | Insight

Gut microbiome and bladder cancer: A new link through nitrosamine metabolism

Enrique Grande shared a post on LinkedIn: "Gut microbiome and bladder cancer: A new link…

Oct 18, 2024, 13:54 | Blog

What if we could detect bladder cancer with a simple urine test? - Queen's University Belfast

Queen's University Belfast shared a post on LinkedIn: "What if we could detect bladder cancer with…

Oct 17, 2024, 12:51 | Insight

What do you envision for the bladder cancer landscape with the addition of ADCs to the treatment armamentarium?

Uromigos made the following post on X: “The Uromigos Live24 panel session on whether antibody…

Oct 16, 2024, 08:04 | Insight

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…

Oct 13, 2024, 22:28 | Insight

Nuradh Joseph: Honoured to speak on bladder cancer and radiotherapy related research at ASCOMOS2024

Nuradh Joseph, Editor in Chief at the Royal College of Radiologists, shared a post on…

Oct 12, 2024, 14:19 | Blog

Excellence in Oncology Care - Pivotal Role Checkpoint Blockade in Bladder Cancer at Uro-Oncology Session

Excellence in Oncology Care - EIOC shared on X: ''See you at the Uro-Oncology Session…

Oct 11, 2024, 19:37 | Insight

María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga recently shared a post on LinkedIn: “Study Uncovers Mutations and DNA…

Oct 11, 2024, 17:45 | Blog

Andrea Apolo about the latest trials and practice changes in bladder cancer

Bogdana Schmidt, Urologic Oncologist at Huntsman Cancer Institute, shared a post about a conversation with…

Oct 10, 2024, 16:05 | Blog

Personalised radiotherapy shows promise in Bladder Cancer - The Institute of Cancer Research

The Institute of Cancer Research posted on LinkedIn: "NEWS: Personalised radiotherapy could offer a kinder…

Oct 10, 2024, 14:16 | Dialogues

NIAGARA Study Insights: Durvalumab and Chemotherapy in Bladder Cancer Treatment | Dr. Petros Grivas

In this episode of OncoDaily, Dr. Petros Grivas joins host Chandler Park to discuss the…

Oct 7, 2024, 08:24 | Insight

Pivotal trial of extended lymphadenectomy vs standard procedure for muscle-invasive bladder cancer

The New England Journal of Medicine shared an article by Seth P. Lerner on X:…

Oct 6, 2024, 14:08 | Blog

Yüksel Ürün: Whole-pelvis radiation therapy in muscle-invasive bladder cancer

Yüksel Ürün posted on X about recent paper by Gautier Marcq et al., titled "Benefit…

Oct 6, 2024, 13:39 | Insight

Sabine Brookman-May: SWOGS1011 finally published in NEJM

Sabine Brookman-May shared a post on X by NEJM about a recent paper by Seth…

Oct 3, 2024, 05:51 | Blog

María Natalia Gandur Quiroga: Muscle-Invasive Bladder Cancer in Non-Curative Patients

María Natalia Gandur Quiroga posted on X about recent paper by Félix Guerrero-Ramos et al.,…

Oct 1, 2024, 16:09 | Blog

Vedang Murthy presented results of the phase III BART trial at ASTRO24

Dr. Vedang Murthy, MD, is a Professor and Radiation Oncologist at Tata Memorial Hospital, Mumbai,…

Sep 30, 2024, 16:54 | Insight

Tom Powles: 1st perioperative immune therapy study to show an OS in bladder cancer

Tom Powles shared an article on X: "Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder…

Sep 24, 2024, 13:31 | Blog

Sabine D. Brookman-May: MA supports EFS as a surrogate for OS in Muscle invasive bladder cancer after neoadjuvant treatment

Sabine D. Brookman-May shared a post on X: ''This MA supports Event-free survival as a…

Sep 23, 2024, 15:50 | Insight

Guru Sonpavde: ESMO24 bladder cancer practice-changing highlight

Guru Sonpavde, Genitourinary Oncology and Phase I Clinical Trials Director of Chair of Bladder Cancer…

Sep 21, 2024, 13:59 | Blog

Roberto Iacovelli: The way to increase OS in bladder cancer

Roberto Iacovelli shared a post on X: ''After years and years of inconclusive trials in…

Sep 21, 2024, 13:04 | Blog

Guru Sonpavde: Adjuvant pembrolizumab improved outcomes in MIBC

Guru Sonpavde, Genitourinary Oncology and Phase I Clinical Trials Director of Chair of Bladder Cancer…

Sep 21, 2024, 01:27 | Insight

Fabio Puglisi: How liquid biopsies can transform TNBC care

Fabio Puglisi shared on X: “Thrilled to share our new publication. Explore how liquid biopsies…

Sep 19, 2024, 15:48 | Insight

Tom Powles: The 1st perioperative immune therapy study to show an OS in bladder cancer

Tom Powles shared a post on X: “Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder…

Sep 19, 2024, 14:33 | Insight

Prognostic Perception and Quality of Life in Patients with Metastatic Renal and Bladder Cancer

JCO Global Oncology shared a post on X: “Perceptions and Expectations: A Study on Prognostic…

Sep 19, 2024, 14:28 | Insight

Applications are OPEN for BCAN's Career Development Award

Bladder Cancer Advocacy Network shared a post on X: “Please share: Bladder Cancer researchers: Applications…

Sep 18, 2024, 15:00 | Blog

Chandler Park: SunRise-1 study ESMO24 update

Chandler Park shared a post on X: "SunRise-1 study ESMO24 update. TAR-200 +/- cetrelimab in patients…

Sep 17, 2024, 15:05 | Blog

Patrizia Giannatempo: Honored to have chaired a symposium on bladder and prostate cancer at ESMO24

Patrizia Giannatempo shared a post on X: ''Honored to have chaired a symposium on bladder…

Sep 16, 2024, 15:00 | Insight

Insights from ESMO24 Day 3

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…

Sep 12, 2024, 15:37 | Blog

Bishoy M. Faltas: Innovation Award to develop Biodigital Avatars to guide personalized treatments for Bladder Cancer

Bishoy M. Faltas shared a post on X: "Thanks Weill Department of Medicine for covering our…

Sep 11, 2024, 16:34 | Insight

Andrea Necchi: Our next piece of the neoadjuvant puzzle in muscle-invasive bladder cancer

Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared a post on X about…

Sep 10, 2024, 05:00 | Blog

Tian Zhang: Lots of bladder cancer data coming at ESMO24

Tian Zhang shared a post on X by Tom Powles adding: "Lots of bladder cancer…

Sep 7, 2024, 15:45 | Blog

Dimitra R. Bakaloudi: Evaluating TMB and MSI in patients with Urothelial cancer treated with ICIs

Dimitra R. Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X about…

Sep 7, 2024, 09:36 | Blog

Nick James: Pilot Phase of the Man Van project is out

Nick James, Professor of Prostate and Bladder Cancer Research at The Institute of Cancer Research,…

Sep 2, 2024, 08:57 | Blog

Rasha Aboelhassan: Which maintenance immunotherapy should we choose for stage IV urothelial cancer

Rasha Aboelhassan shared a post on LinkedIn: "Which maintenance immunotherapy should we choose for stage…

Sep 1, 2024, 20:21 | Blog

Andrea Necchi: MRI should be a routine for daily management of MIBC

Andrea Necchi, Associate Editor at Journal of Clinical Oncology, shared Nick James's, Professor of Prostate…

Sep 1, 2024, 04:23 | Insight

Joaquim Bellmunt: Proud of learning from negative trials

Toni Choueiri shared a post by Joaquim Bellmunt, Director Bladder Cancer Center at Dana-Farber Cancer…

Aug 31, 2024, 14:28 | Blog

Petros Grivas: Excited to present bladder cancer updates at Libya

Petros Grivas shared a post on X: "After Morocco and Uganda, am excited to present…

Aug 27, 2024, 22:03 | Insight

Amir Horowitz: Treatment strategies and management of BCG-unresponsive NMIBC

Amir Horowitz shared on X: “Honored to play small role in shaping guidelines for treatment…

Aug 27, 2024, 21:41 | Blog

Ashish M. Kamat: IBCG24 has officially concluded

Ashish M. Kamat, Endowed Professor of Urologic Oncology at MD Anderson Cancer Centre, shared on…

Aug 27, 2024, 03:05 | Insight

Ashish M. Kamat: Bladder-sparing Therapy for BCG–unresponsive NMIBC

Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, shared a post…

Aug 26, 2024, 21:30 | Blog

Tian Zhang: 3 weeks til ESMO24!

Tian Zhang shared a post by ESMO on X, adding the following: “T -3 weeks…

Aug 24, 2024, 20:24 | Blog

Petros Grivas: Great to have dedicated colleagues in fight vs bladder cancer

Petros Grivas shared a post on X: "So excited to chat with rising superstar Karine Tawagi…

Aug 21, 2024, 13:41 | Insight

Sabine D. Brookman-May: Achieving Benchmarks for National Quality Indicators Reduces Recurrence and Progression

Sabine D. Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X:…

Aug 20, 2024, 10:39 | Insight

Vedang Murthy: Quality of life among patients with radical cystectomy versus bladder preservation

Vedang Murthy, Professor GU-Radiation Oncology at Tata Memorial Centre Mumbai, shared a post on X: “New…

Aug 19, 2024, 11:08 | Insight

Laura Bukavina: A prognostic model for bladder cancer, focusing on tumor microenvironment-model outperforms stage for outcome

Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared a post…

Aug 18, 2024, 07:37 | Blog

Mark Tyson: Honored to be at Vanderbilt Urology for the Hassell Franklin Lectureship

Mark Tyson shared on X: "Honored to be at Vanderbilt Urology this week for the…

Aug 17, 2024, 08:07 | Insight

Liang Cheng: An exciting time to study bladder cancer

Liang Cheng shared on LinkedIn: "I am very happy to know that our collaborative research…

Aug 13, 2024, 09:24 | Blog

Ashish M. Kamat: Only two weeks until the IBCG24 Retreat!

Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared a post…

Aug 12, 2024, 17:06 | Blog

Angie Smith: One of the best conferences of the year - BCANTT24

Angie Smith shared on X: "One of the best conferences of the year - BCANTT24 (Bladder…